Triple

T5689098
Position Surface form Disambiguated ID Type / Status
Subject CLARITY AD E125383 entity
Predicate conditionStudied P65953 FINISHED
Object Alzheimer’s disease E20980 NE FINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Alzheimer’s disease | Statement: [CLARITY AD, conditionStudied, Alzheimer’s disease]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Alzheimer’s disease
Context triple: [CLARITY AD, conditionStudied, Alzheimer’s disease]
  • A. Alzheimer's disease chosen
    Alzheimer's disease is a progressive neurodegenerative disorder characterized by memory loss, cognitive decline, and behavioral changes, and is the most common cause of dementia in older adults.
  • B. Alzheimer
    Alzheimer is a German surname most famously associated with Alois Alzheimer, the neurologist after whom Alzheimer’s disease is named.
  • C. Alzon
    The Alzon is a river in southern France that flows through the Gard department, including the town of Uzès.
  • D. Lewy body dementia
    Lewy body dementia is a progressive neurodegenerative disorder characterized by cognitive decline, visual hallucinations, fluctuating alertness, and Parkinsonian movement symptoms, caused by abnormal protein deposits called Lewy bodies in the brain.
  • E. MCI-Shirley
    MCI-Shirley is a medium- and minimum-security state prison for men located in Shirley, Massachusetts.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: conditionStudied
Context triple: [CLARITY AD, conditionStudied, Alzheimer’s disease]
  • A. riskFactorTypeStudied
    Indicates that a particular type of risk factor is the subject of study or analysis in a given context.
  • B. canBeStudiedAs
    Indicates that something is suitable or appropriate to be examined, analyzed, or researched as a subject of study.
  • C. studiedWithin
    Indicates that one entity pursued studies or academic work within the scope, context, or boundaries defined by another entity (such as an institution, program, or field).
  • D. studiedBy
    Indicates that a subject (such as a field, topic, or object) is examined, researched, or learned by an agent (such as a person or group).
  • E. widelyStudiedIn
    Indicates that something has been extensively researched, analyzed, or examined within a particular field, domain, or context.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c0082bb19c8190823a4facd3cba79b completed March 22, 2026, 3:18 p.m.
NER Named-entity recognition batch_69c029014588819094a2a0f6f9b66bab completed March 22, 2026, 5:38 p.m.
NED1 Entity disambiguation (via context triple) batch_69c05a47457c8190bc75f11a7f011a8a completed March 22, 2026, 9:08 p.m.
PD Predicate disambiguation batch_69c021c0e0408190ab6c3cd3f907e80f completed March 22, 2026, 5:07 p.m.
PDg Predicate description generation batch_69c028fec2bc819083f5dca6a8d9d435 completed March 22, 2026, 5:38 p.m.
Created at: March 22, 2026, 3:44 p.m.